Press Release

April 11, 2022
Dipeptidyl peptidase 3 biomarker to drive precision medicine in COVID-19
April 11, 2022
Dipeptidyl peptidase 3 biomarker to drive precision medicine in COVID-19
March 25, 2022
DPP3 predicts organ failure and in-hospital mortality in postoperative patients
February 01, 2022
DPP3 biomarker to advance prediction of organ function progression in septic patients
September 16, 2020
4TEEN4’s first-in-class therapeutic antibody Procizumab restores heart function in life-threatening cardiac depression induced by sepsis


January 05, 2022
The emerging role of dipeptidyl peptidase 3 in pathophysiology
January 04, 2022
Circulating dipeptidyl peptidase (cDPP3)-A marker for end-stage heart failure?
January 01, 2022
Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosis
December 08, 2021
High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort.
August 24, 2021
Circulating dipeptidyl peptidase 3 on intensive care unit admission is a predictor of organ dysfunction and mortality
June 01, 2021
Plasma proenkephalin A 119-159 and dipeptidyl peptidase 3 on admission after cardiac arrest help predict long-term neurological outcome
June 01, 2021
Circulating biomarkers to assess cardiovascular function in critically ill
March 15, 2021
Circulatory dipeptidyl peptidase 3 (cDPP3) is a potential biomarker for early detection of secondary brain injury after aneurysmal subarachnoid hemorrhage
February 21, 2021
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study.
December 30, 2020
Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.
November 20, 2020
In-hospital mortality and organ failure after open and endovascular thoraco-abdominal aortic surgery can be predicted by increased levels of circulating dipeptidyl peptidase 3.